Dominik Vonficht
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.
Journal: Blood cancer discovery
Published: July 02, 2025
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.
Journal: Science immunology
Published: February 07, 2025
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.
Journal: Nature genetics
Published: December 06, 2024
Ultra-high-scale cytometry-based cellular interaction mapping.
Journal: Nature methods
Published: March 07, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
Journal: Nature communications
Published: October 16, 2023
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation.
Journal: Nature immunology
Published: March 21, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
Journal: Journal of hematology & oncology
Published: February 28, 2023
Aged intestinal stem cells propagate cell-intrinsic sources of inflammaging in mice.
Journal: Developmental cell
Published: August 16, 2022
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
Journal: Nature communications
Published: April 04, 2022
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
Journal: The Journal of clinical investigation
Published: June 15, 2021
Last Updated: 09/26/2026